Lixisenatide resensitizes the insulin-secretory response to intravenous glucose challenge in people with type 2 diabetes - a study in both people with type 2 diabetes and healthy subjects
Becker, R. H. A., Stechl, J., Msihid, J., Kapitza, C.
Published in Diabetes, obesity & metabolism (01.09.2014)
Published in Diabetes, obesity & metabolism (01.09.2014)
Get full text
Journal Article
Effects of Hoe 065, a compound structurally related to inhibitors of angiotensin converting enzyme, on acetylcholine metabolism in rat brain
Wiemer, G, Becker, R, Gerhards, H, Hock, F, Stechl, J, Rüger, W
Published in European journal of pharmacology (04.07.1989)
Published in European journal of pharmacology (04.07.1989)
Get more information
Journal Article
Effects of the novel compound, Hoe 065, upon impaired learning and memory in rodents
Hock, F J, Gerhards, H J, Wiemer, G, Stechl, J, Rüger, W, Urbach, H
Published in European journal of pharmacology (14.11.1989)
Published in European journal of pharmacology (14.11.1989)
Get more information
Journal Article